Personalized Medicine through Circulating Tumor Cells: The New Dimension in Cancer Research

2013 ◽  
Vol 02 (03) ◽  
Author(s):  
Shailender Singh Kanwar
Cancers ◽  
2020 ◽  
Vol 12 (6) ◽  
pp. 1632 ◽  
Author(s):  
Anthony Genna ◽  
Aline M. Vanwynsberghe ◽  
Amélie V. Villard ◽  
Charles Pottier ◽  
Julien Ancel ◽  
...  

Epithelial–mesenchymal transitions (EMTs) generate hybrid phenotypes with an enhanced ability to adapt to diverse microenvironments encountered during the metastatic spread. Accordingly, EMTs play a crucial role in the biology of circulating tumor cells (CTCs) and contribute to their heterogeneity. Here, we review major EMT-driven properties that may help hybrid Epithelial/Mesenchymal CTCs to survive in the bloodstream and accomplish early phases of metastatic colonization. We then discuss how interrogating EMT in CTCs as a companion biomarker could help refine cancer patient management, further supporting the relevance of CTCs in personalized medicine.


2021 ◽  
pp. 489-508
Author(s):  
Jin Sun Lee ◽  
Mark Jesus M. Magbanua ◽  
Marc R. Jabon ◽  
John W. Park

2017 ◽  
Vol 24 (6) ◽  
pp. R223-R237 ◽  
Author(s):  
Maria Chiara Zatelli ◽  
Erika Maria Grossrubatscher ◽  
Elia Guadagno ◽  
Concetta Sciammarella ◽  
Antongiulio Faggiano ◽  
...  

The prognosis of neuroendocrine neoplasms (NENs) is widely variable and has been shown to associate with several tissue- and blood-based biomarkers in different settings. The identification of prognostic factors predicting NEN outcome is of paramount importance to select the best clinical management for these patients. Prognostic markers have been intensively investigated, also taking advantage of the most modern techniques, in the perspective of personalized medicine and appropriate resource utilization. This review summarizes the available data on the possible role of circulating tumor cells and microRNAs as prognostic markers in NENs.


2013 ◽  
Vol 24 (2) ◽  
pp. 221-228 ◽  
Author(s):  
Rahul A. Sheth ◽  
Robin Hesketh ◽  
Amy R. Deipolyi ◽  
Rahmi Oklu

2016 ◽  
Vol 160 (3) ◽  
pp. 411-424 ◽  
Author(s):  
Jin Sun Lee ◽  
Mark Jesus M. Magbanua ◽  
John W. Park

Author(s):  
Jin Sun Lee ◽  
Mark Jesus M. Magbanua ◽  
Marc R. Jabon ◽  
John W. Park

2018 ◽  
Vol 25 (35) ◽  
pp. 4616-4637 ◽  
Author(s):  
Matteo Turetta ◽  
Fabio Del Ben ◽  
Giulia Brisotto ◽  
Eva Biscontin ◽  
Michela Bulfoni ◽  
...  

In the present review, we describe three hot topics in cancer research such as circulating tumor cells, exosomes, and 3D environment models. The first section is dedicated to microfluidic platforms for detecting circulating tumor cells, including both affinity-based methods that take advantage of antibodies and aptamers, and “label-free” approaches, exploiting cancer cells physical features and, more recently, abnormal cancer metabolism. In the second section, we briefly describe the biology of exosomes and their role in cancer, as well as conventional techniques for their isolation and innovative microfluidic platforms. In the third section, the importance of tumor microenvironment is highlighted, along with techniques for modeling it in vitro. Finally, we discuss limitations of two-dimensional monolayer methods and describe advantages and disadvantages of different three-dimensional tumor systems for cell-cell interaction analysis and their potential applications in cancer management.


2017 ◽  
Vol 41 (2) ◽  
pp. 755-768 ◽  
Author(s):  
Wei Zhang ◽  
Wenjie Xia ◽  
Zhengye Lv ◽  
Chao Ni ◽  
Yin Xin ◽  
...  

Precision medicine and personalized medicine are based on the development of biomarkers, and liquid biopsy has been reported to be able to detect biomarkers that carry information on tumor development and progression. Compared with traditional ‘solid biopsy’, which cannot always be performed to determine tumor dynamics, liquid biopsy has notable advantages in that it is a noninvasive modality that can provide diagnostic and prognostic information prior to treatment, during treatment and during progression. In this review, we describe the source, characteristics, technology for detection and current situation of circulating tumor cells, circulating free DNA and exosomes used for diagnosis, recurrence monitoring, prognosis assessment and medication planning.


2012 ◽  
Vol 2 ◽  
Author(s):  
Bryan T. Greene ◽  
Andrew D. Hughes ◽  
Michael R. King

Sign in / Sign up

Export Citation Format

Share Document